Navigation Links
WuXi PharmaTech Announces First-Quarter 2011 Results
Date:5/10/2011

and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxiapptec.com.

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com.

Use of Non-GAAP and Pro-Forma Financial MeasuresWe have provided the first-quarter 2010 and 2011 gross profit, gross margin, operating income, operating margin, net income, and earnings per ADS on a non-GAAP basis, which excludes share-based compensation expenses and amortization and deferred tax impact of acquired intangible assets. We believe both management and investors benefit from referring to these non-GAAP financial measures in assessing our financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing underlying business performance and operating trends. We expect to continue to provide net income and earnings per ADS on a non-GAAP basis using a consistent method on a quarterly basis.

You should not view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and should refer to the reconciliation of GAAP measures to non-GAAP measures for the indicated periods attached hereto.


'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
8. WuXi PharmaTech Announces First-Quarter 2010 Results
9. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
10. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
11. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... TWi Pharmaceuticals, Inc. ("TWi", Stock Ticker:4180.TT) today ... USA , has obtained state sales licenses from ... been in close contact with the major nationwide retail ... own label specialty generic products sold through these nationwide ... According to IMS Health, the U.S. pharma ...
(Date:4/16/2015)... BEDFORD, Mass. , April 16, 2015 /PRNewswire/ ... an important cervical cancer screening study i ... , a peer-reviewed journal of the American Cancer ... Quest Diagnostics and the University of Pittsburgh Medical Center, supports ... screening, which recommend that women 30-65 years of ...
(Date:4/16/2015)... 2015 Today, Kenneth C. Frazier , chairman ... was elected chairman of the Board of the Pharmaceutical Research ... president and CEO John J. Castellani announced that ... New Officers Elected to PhRMA Board Frazier ... C. Read , chairman and CEO of Pfizer, Inc. Also ...
Breaking Medicine Technology:Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5
... Duska Therapeutics,Inc., (OTC Bulletin Board: DSKA), announced today that ... protocol for review under a Special,Protocol Assessment (SPA) procedure ... Subject to securing an ... prospective, double-blind, placebo-controlled and randomized Phase 3,clinical trial with ...
... NEW YORK, Nov. 20 Clinical data from a ... Symposium shows DVT,treatment with the Trellis(R) Peripheral Infusion System ... the blood clot in most,patients in about 20 minutes. ... called isolated pharmacomechanical thrombolysis, restores,blood flow more quickly and ...
Cached Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3
(Date:4/17/2015)... April 17, 2015 Consumers who prefer ... without modifications can now use the Insurance Pros USA ... insurance policy rates that are featured by leading companies ... plans that are offered are mixed between three of ... to 79. There are now term, universal and whole ...
(Date:4/17/2015)... At the end of February 2015, ... “Salute to the Oscars” in the Stardust Penthouse on ... the impressive Los Angeles skyline. These events honoring the ... LA’s leading producer of sustainable product placement in TV ... premier providers of eco-friendly and socially conscious products and ...
(Date:4/17/2015)... La Farge, WI (PRWEB) April 17, 2015 ... farmers, will participate in the United Nations’ International Year ... From April 19-25, Organic Valley farmer-owners and employees will ... coast, learning from experts along the way about the ... , Hailing from as far as Maine, Wisconsin, ...
(Date:4/17/2015)... Calvary Hospital recently announced Timothy P. Barr will be ... May 11. The Fund directs all fundraising efforts in support ... J. Spinelli, who retired several months ago. , “We are ... the important work that the Fund does every year,” said ... expand and bring our signature care to people who need ...
(Date:4/17/2015)... released a new blog post explaining the dangers of sleeping ... rates . , Falling asleep at the wheel can ... impact on auto insurance prices. The premiums will go up ... newly released blog post talks more about drowsiness at the ... is now possible to find low cost car insurance plans ...
Breaking Medicine News(10 mins):Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 2Health News:Timothy P. Barr Appointed Executive Vice President of Calvary Fund 3Health News:Accidents Caused By Sleeping at The Wheel Can Increase Auto Insurance Costs 2
... who are evaluated for liver diseases such as hepatitis ... determine the extent of disease progression. For patients who ... have alternatives options to consider. Elastography and serum markers ... published in the June issue of Hepatology , ...
... 2011) - The new visual icon released today by the ... and Human Services (HHS), called MyPlate, offers simple and actionable ... to the basics, illustrating how to create a healthful plate ... foods. Recognized by the 2010 Dietary Guidelines Advisory Committee as ...
... June 2 (HealthDay News) -- A new study finds that a ... virus that can cause birth defects and hearing loss. The ... or treating deafness in children infected with the virus, known as ... do a good job of detecting the infection, which is passed ...
... most commonly used to treat nail fungus, may keep prostate ... men with advanced disease. Details of the finding, from ... for presentation on Saturday, June 4 at the 2011 American ... Currently, the drug is approved to treat fungal infections in ...
... who undergo lung-sparing surgery in combination with photodynamic therapy ... the conventional therapy of extrapleural pneumonectomy (EPP) (or en ... PDT, indicates new research from the Raymond and Ruth ... The research is published in the June 2011 issue ...
... from North Carolina State University shows that talking about safer ... community. The finding may help efforts to promote safer sex ... also sheds light on broader questions related to safer sex ... the fact that we,re seeing evidence of devastatingly high HIV ...
Cached Medicine News:Health News:Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis 2Health News:Beef: America's favorite protein is an essential building block 2Health News:Saliva Test Spots Virus That Can Cause Hearing Loss in Newborns 2Health News:Antifungal drug delays need for chemo in advanced prostate cancer 2Health News:Combination therapy shows promise for rare, deadly cancer caused by asbestos 2Health News:Combination therapy shows promise for rare, deadly cancer caused by asbestos 3Health News:Combination therapy shows promise for rare, deadly cancer caused by asbestos 4Health News:Safer sex: Study examines sexual communication in transgender community 2
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: